Thyroid Dysfunction Mild With Cancer Immunotherapy
In a real-world study, the prevalence of immune checkpoint inhibitor–associated thyroid dysfunction was greater than 50%, but cases were mild and were even linked to better survival.
Medscape Medical News
source https://www.medscape.com/viewarticle/992691?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992691?src=rss
Comments
Post a Comment